Cargando…

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease

Recently, numerous studies have shown that disruption of the mucus barrier plays an important role in the exacerbation of inflammatory bowel disease, particularly in ulcerative colitis. Alterations in the mucus barrier are well supported by published data and are widely accepted. The use of fluoresc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jing, Shen, Xiao, Li, Yi, Guo, Zhen, Zhu, Weiming, Zuo, Lugen, Zhao, Jie, Gu, Lili, Gong, Jianfeng, Li, Jieshou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728657/ https://www.ncbi.nlm.nih.gov/pubmed/26784223 http://dx.doi.org/10.3390/nu8010044

Ejemplares similares

CONSORT: Different End-Points of Preoperative Nutrition and Outcome of Bowel Resection of Crohn Disease: A Randomized Clinical Trial
por: Zhu, Weiming, et al.
Publicado: (2015)

Role of Exclusive Enteral Nutrition in the Preoperative Optimization of Patients With Crohn's Disease Following Immunosuppressive Therapy
por: Li, Yi, et al.
Publicado: (2015)

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease
por: Wei, Yao, et al.
Publicado: (2015)

Preoperative Nutritional Therapy Reduces the Risk of Anastomotic Leakage in Patients with Crohn's Disease Requiring Resections
por: Guo, Zhen, et al.
Publicado: (2016)

Dietary Fiber Intake is Associated with Increased Colonic Mucosal GPR43+ Polymorphonuclear Infiltration in Active Crohn’s Disease
por: Zhao, Mingli, et al.
Publicado: (2015)

High Visceral to Subcutaneous Fat Ratio Is Associated with Increased Postoperative Inflammatory Response after Colorectal Resection in Inflammatory Bowel Disease
por: Wei, Yao, et al.
Publicado: (2018)

Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-Analysis
por: Gong, Jianfeng, et al.
Publicado: (2013)

The Interaction of Large Bowel Microflora with the Colonic Mucus Barrier
por: Pearson, Jeffrey P., et al.
Publicado: (2010)

Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease
por: Al-Shaibi, Ahmad A., et al.
Publicado: (2021)

Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn’s Disease
por: Guo, Zhen, et al.
Publicado: (2016)

Preoperative Intra-abdominal Sepsis, Not Penetrating Behavior Itself, Is Associated With Worse Postoperative Outcome After Bowel Resection for Crohn Disease: A Retrospective Cohort Study
por: Zhang, Tenghui, et al.
Publicado: (2015)

Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
por: Wei, Yao, et al.
Publicado: (2015)

The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020)

Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice
por: Zhang, Tenghui, et al.
Publicado: (2016)

4483 Activity and Abundance of Mucus-degrading Microbes in Inflammatory Bowel Disease
por: Ostrowski, Matthew, et al.
Publicado: (2020)

Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora
por: Wei, Yao, et al.
Publicado: (2016)

Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2021)

Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: preliminary data
por: Zhao, Chenyan, et al.
Publicado: (2018)

Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions
por: Popov, Alexey
Publicado: (2020)

Intelectin-1 binds and alters the localization of the mucus barrier–modifying bacterium Akkermansia muciniphila
por: Matute, Juan D., et al.
Publicado: (2022)

Short bowel syndrome presenting with re-feeding syndrome in a Han Chinese patient: a case report
por: Xie, Ying, et al.
Publicado: (2012)

Impact of Developmental Age, Necrotizing Enterocolitis Associated Stress, and Oral Therapeutic Intervention on Mucus Barrier Properties
por: Lock, Jaclyn Y., et al.
Publicado: (2020)

Interactions between microbiota and cervical epithelial, immune, and mucus barrier
por: Dong, Mengting, et al.
Publicado: (2023)

Bryostatin‐1 ameliorated experimental colitis in Il‐10 (−/−) Mice by protecting the intestinal barrier and limiting immune dysfunction
por: Zuo, Lugen, et al.
Publicado: (2019)

The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis
por: Hu, Qiongyuan, et al.
Publicado: (2017)

Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis
por: Ke, Haoran, et al.
Publicado: (2021)

Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study
por: Gu, Lili, et al.
Publicado: (2017)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

The composition of the gut microbiota shapes the colon mucus barrier
por: Jakobsson, Hedvig E, et al.
Publicado: (2015)

Modulating intestinal mucus barrier for nanoparticles penetration by surfactants
por: Zhang, Xin, et al.
Publicado: (2019)

Long intestinal tube splinting prevents postoperative adhesive small-bowel obstruction in sclerosing encapsulating peritonitis
por: Li, Min, et al.
Publicado: (2014)

The Effect of Tartaric Acid on Morbid Accumulations of Mucus in the Stomach and Bowels
por: Morgan, James
Publicado: (1837)

Effects of Modified Zhisou Powder on Airway Mucus Production in Chronic Obstructive Pulmonary Disease Model Rats with Cold-Dryness Syndrome
por: Zhen, Gao, et al.
Publicado: (2018)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier
por: Sadio, Ana, et al.
Publicado: (2014)

An appraisal of clinical practice guidelines for constipation: a right attitude towards to guidelines
por: Tian, Hongliang, et al.
Publicado: (2016)

The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability
por: Stiegeler, Sarah, et al.
Publicado: (2021)

Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease
por: Bhattarai, Yogesh, et al.
Publicado: (2020)

Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein
por: Dong, Wujun, et al.
Publicado: (2020)

A sticky end for gastrointestinal helminths; the role of the mucus barrier
por: Sharpe, C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vt2976vusfnol7mrpu68do3o2k